Please assess the completion status of the following clinical trial:

Trial Title: A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Both Sexes, Aged 20 Years Or Older~* Japanese Participants With Skin And Soft Tissue Infections, Septicemia, or RIE Known Or Suspected To Be Caused By MRSA~* Written Informed Consent~Exclusion Criteria:~* Participants With Skin and Soft Tissue infections That Can Be Treated By Surgery Alone~* Participants With Pneumonia

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MK-3009 (daptomycin) 4 mg/kg (Type: EXPERIMENTAL): None
- Vancomycin (Type: ACTIVE_COMPARATOR): None
- MK-3009 (daptomycin) 6 mg/kg (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).